{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T04:52:59Z","timestamp":1768798379392,"version":"3.49.0"},"reference-count":111,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Public Health"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.puhe.2011.01.016","type":"journal-article","created":{"date-parts":[[2011,7,24]],"date-time":"2011-07-24T19:26:26Z","timestamp":1311535586000},"page":"464-475","source":"Crossref","is-referenced-by-count":24,"title":["Appraisal of the burden of genital warts from a healthcare and individual patient perspective"],"prefix":"10.1016","volume":"125","author":[{"given":"C.D.","family":"Scarbrough Lefebvre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Van Kriekinge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"de Sanjose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.puhe.2011.01.016_bib1","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1086\/522863","article-title":"The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries","volume":"196","author":"Kjaer","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.puhe.2011.01.016_bib2","first-page":"3860","article-title":"What is the significance of the HPV epidemic?","volume":"15","author":"Anorlu","year":"2008","journal-title":"Can J Urol"},{"key":"10.1016\/j.puhe.2011.01.016_bib3","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jadohealth.2005.09.011","article-title":"Impact of HPV infection in adolescent populations","volume":"37","author":"Moscicki","year":"2005","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.puhe.2011.01.016_bib4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11908-000-0083-z","article-title":"Infection with human papillomavirus: update on epidemiology, diagnosis, and treatment","volume":"2","author":"Hagensee","year":"2000","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.puhe.2011.01.016_bib5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/oxfordjournals.epirev.a036020","article-title":"Epidemiology of genital human papillomavirus infection","volume":"10","author":"Koutsky","year":"1988","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.puhe.2011.01.016_bib6","series-title":"Testing times. HIV and other sexually transmitted infections in the United Kingdom","author":"UK Collaborative Group for HIV and STI Surveillance","year":"2007"},{"key":"10.1016\/j.puhe.2011.01.016_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","article-title":"Classification of papillomaviruses","volume":"324","author":"de Villiers","year":"2004","journal-title":"Virology"},{"issue":"Suppl. 1","key":"10.1016\/j.puhe.2011.01.016_bib8","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.ogx.0000221010.82943.8c","article-title":"Human papillomavirus: the burden of infection","volume":"61","author":"Wiley","year":"2006","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.puhe.2011.01.016_bib9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens \u2013 part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.puhe.2011.01.016_bib10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1473-3099(08)70079-3","article-title":"Genital warts: mountains or molehills?","volume":"8","author":"Hull","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.puhe.2011.01.016_bib11","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1086\/505982","article-title":"Genital human papillomavirus infection","volume":"43","author":"Dunne","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.puhe.2011.01.016_bib12","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1086\/590560","article-title":"Human papillomavirus genotype distribution in external acuminata condylomata: a large French national study (EDiTH IV)","volume":"47","author":"Aubin","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.puhe.2011.01.016_bib13","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/597071","article-title":"Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine","volume":"199","author":"Garland","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.puhe.2011.01.016_bib14","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1086\/498164","article-title":"Randomized controlled trial of an adjuvanted human papillomavirus (HPV) type 6 L2E7 vaccine: infection of external anogenital warts with multiple HPV types and failure of therapeutic vaccination","volume":"192","author":"Vandepapeliere","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.puhe.2011.01.016_bib15","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1258\/ijsa.2008.008040","article-title":"Human papillomavirus type-distribution in condylomata acuminata of mainland China: a meta-analysis","volume":"19","author":"Wang","year":"2008","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.puhe.2011.01.016_bib16","first-page":"1","article-title":"Human papillomaviruses","volume":"90","year":"2007","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"10.1016\/j.puhe.2011.01.016_bib17","series-title":"Lower genital tract precancer: colposcopy, pathology and treatment","author":"Singer","year":"2000"},{"key":"10.1016\/j.puhe.2011.01.016_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0002-9343(97)00177-0","article-title":"Epidemiology of genital human papillomavirus infection","volume":"102","author":"Koutsky","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/j.puhe.2011.01.016_bib19","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1258\/0956462054679214","article-title":"Prevalence and incidence of human papillomavirus infection in women in the USA: a systematic review","volume":"16","author":"Revzina","year":"2005","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.puhe.2011.01.016_bib20","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/OLQ.0b013e31815abaef","article-title":"Seroepidemiology of human papillomavirus type 11 in the United States: results from the third National Health and Nutrition Examination Survey, 1991\u20131994","volume":"35","author":"Hariri","year":"2008","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.puhe.2011.01.016_bib21","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.297.8.813","article-title":"Prevalence of HPV infection among females in the United States","volume":"297","author":"Dunne","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.puhe.2011.01.016_bib22","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/01.olq.0000204545.89516.0a","article-title":"Human papillomavirus infection among sexually active young women in the United States: implications for developing a vaccination strategy","volume":"33","author":"Manhart","year":"2006","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.puhe.2011.01.016_bib23","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1001\/jama.265.4.472","article-title":"Genital human papillomavirus infection in female university students as determined by a PCR-based method","volume":"265","author":"Bauer","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.puhe.2011.01.016_bib24","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/infdis\/171.4.1026","article-title":"Human papillomavirus infection is transient in young women: a population-based cohort study","volume":"171","author":"Evander","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.puhe.2011.01.016_bib25","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/ijc.2910490609","article-title":"PCR-detected genital papillomavirus infection: prevalence and association with risk factors for cervical cancer","volume":"49","author":"Rohan","year":"1991","journal-title":"Int J Cancer"},{"key":"10.1016\/j.puhe.2011.01.016_bib26","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1086\/368220","article-title":"Human papillomavirus infection in men attending a sexually transmitted disease clinic","volume":"187","author":"Baldwin","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.puhe.2011.01.016_bib27","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1086\/428850","article-title":"Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica","volume":"191","author":"Herrero","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.puhe.2011.01.016_bib28","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1086\/521192","article-title":"Genital human papillomavirus infection in men: incidence and risk factors in a cohort of university students","volume":"196","author":"Partridge","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.puhe.2011.01.016_bib29","first-page":"485","article-title":"The natural history of type-specific human papillomavirus infections in female university students","volume":"12","author":"Richardson","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.puhe.2011.01.016_bib30","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/01.olq.0000145851.76025.ad","article-title":"Rate and predictors of new genital warts claims and genital warts-related healthcare utilization among privately insured patients in the United States","volume":"31","author":"Koshiol","year":"2004","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.puhe.2011.01.016_bib31","first-page":"1","article-title":"Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Markowitz","year":"2007","journal-title":"MMWR Recomm Rep"},{"issue":"Suppl. 2","key":"10.1016\/j.puhe.2011.01.016_bib32","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1086\/342109","article-title":"External genital warts: diagnosis, treatment, and prevention","volume":"35","author":"Wiley","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.puhe.2011.01.016_bib33","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1086\/315086","article-title":"Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer","volume":"180","author":"Franco","year":"1999","journal-title":"J Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.puhe.2011.01.016_bib34","first-page":"S1","article-title":"The epidemiology of genital human papillomavirus infection","volume":"24","author":"Trottier","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.puhe.2011.01.016_bib35","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1086\/341782","article-title":"Incidence, prevalence, and clearance of type-specific human papillomavirus infections: the Young Women\u2019s Health Study","volume":"186","author":"Giuliano","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.puhe.2011.01.016_bib36","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0022-3476(98)70445-7","article-title":"The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women","volume":"132","author":"Moscicki","year":"1998","journal-title":"J Pediatr"},{"issue":"Suppl. 3","key":"10.1016\/j.puhe.2011.01.016_bib37","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.vaccine.2006.06.015","article-title":"Chapter 4: burden and management of non-cancerous HPV-related conditions: HPV-6\/11 disease","volume":"24","author":"Lacey","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.puhe.2011.01.016_bib38","first-page":"1","article-title":"Natural history of genital warts","volume":"47","author":"Oriel","year":"1971","journal-title":"Br J Vener Dis"},{"key":"10.1016\/j.puhe.2011.01.016_bib39","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/aje\/kwf180","article-title":"Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students","volume":"157","author":"Winer","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.puhe.2011.01.016_bib40","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1086\/427557","article-title":"Development and duration of human papillomavirus lesions, after initial infection","volume":"191","author":"Winer","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.puhe.2011.01.016_bib41","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1086\/514964","article-title":"External genital warts: report of the American Medical Association Consensus Conference. AMA expert panel on external genital warts","volume":"27","author":"Beutner","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.puhe.2011.01.016_bib42","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/j.jcv.2004.10.020","article-title":"Therapy for genital human papillomavirus-related disease","volume":"32","author":"Lacey","year":"2005","journal-title":"J Clin Virol"},{"issue":"Suppl. 1","key":"10.1016\/j.puhe.2011.01.016_bib43","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1086\/514722","article-title":"Genital warts and their treatment","volume":"28","author":"Beutner","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.puhe.2011.01.016_bib44","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00007435-199207000-00008","article-title":"Human papillomavirus DNA detection in primary anogenital warts and cervical low-grade intraepithelial neoplasias in adults by in situ hybridization","volume":"19","author":"Handley","year":"1992","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.puhe.2011.01.016_bib45","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/oxfordjournals.aje.a117441","article-title":"The spectrum of medical conditions and symptoms before acquired immunodeficiency syndrome in homosexual and bisexual men infected with the human immunodeficiency virus","volume":"141","author":"Holmberg","year":"1995","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.puhe.2011.01.016_bib46","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0002-9378(99)70653-8","article-title":"Prevalence and incidence of gynecologic disorders among women infected with human immunodeficiency virus","volume":"180","author":"Minkoff","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.puhe.2011.01.016_bib47","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00007435-200208000-00001","article-title":"The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts","volume":"29","author":"Silverberg","year":"2002","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.puhe.2011.01.016_bib48","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1258\/0956462053420176","article-title":"How condom use, number of receptive anal intercourse partners and history of external genital warts predict risk for external anal warts","volume":"16","author":"Wiley","year":"2005","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.puhe.2011.01.016_bib49","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/OLQ.0b013e3181632d61","article-title":"Genital warts among 18- to 59-year-olds in the United States, national health and nutrition examination survey, 1999\u20132004","volume":"35","author":"Dinh","year":"2008","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.puhe.2011.01.016_bib50","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1258\/0956462054308459","article-title":"Correlates of sexually transmitted infections in young Australian women","volume":"16","author":"Khan","year":"2005","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.puhe.2011.01.016_bib51","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/00007435-199711000-00003","article-title":"History of genital warts in 10,838 women 20 to 29 years of age from the general population. Risk factors and association with Papanicolaou smear history","volume":"24","author":"Munk","year":"1997","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.puhe.2011.01.016_bib52","doi-asserted-by":"crossref","DOI":"10.2807\/ese.13.45.19032-en","article-title":"The burden of genital warts in Slovenia: results from a national probability sample survey","volume":"13","author":"Klavs","year":"2008","journal-title":"Euro Surveill"},{"key":"10.1016\/j.puhe.2011.01.016_bib53","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00007435-199320060-00004","article-title":"Prevalence and risk factors of genital human papillomavirus (HPV) infections in healthy males: a study on Finnish conscripts","volume":"20","author":"Hippelainen","year":"1993","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.puhe.2011.01.016_bib54","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/00007435-199807000-00002","article-title":"Risk factors for incident and recurrent condylomata acuminata among men. A population-based study","volume":"25","author":"Van Den Eeden","year":"1998","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.puhe.2011.01.016_bib55","first-page":"991","article-title":"Incidence and management of condylomata acuminata by French general physicians","volume":"129","author":"Lukasiewicz","year":"2002","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.puhe.2011.01.016_bib56","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.gyobfe.2006.12.010","article-title":"Anogenital warts incidence, medical management and costs in women consulting gynaecologists in France","volume":"35","author":"Monsonego","year":"2007","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.puhe.2011.01.016_bib57","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1086\/375074","article-title":"The health and economic burden of genital warts in a set of private health plans in the United States","volume":"36","author":"Insinga","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.puhe.2011.01.016_bib58","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archderm.120.4.469","article-title":"Condyloma acuminatum in Rochester, Minn., 1950\u20131978. I. Epidemiology and clinical features","volume":"120","author":"Chuang","year":"1984","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.puhe.2011.01.016_bib59","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1258\/0956462001915949","article-title":"Sexually transmitted infections and use of sexual health services among young Australian women: Women\u2019s Health Australia study","volume":"11","author":"Schofield","year":"2000","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.puhe.2011.01.016_bib60","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/030089160308900103","article-title":"Risk factors associated with genital warts in HIV-positive Brazilian women","volume":"89","author":"Goncalves","year":"2003","journal-title":"Tumori"},{"key":"10.1016\/j.puhe.2011.01.016_bib61","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1258\/0956462054944390","article-title":"Correlation between deoxyribonucleic acid loads of human papillomavirus and recurrence of condylomata acuminata","volume":"16","author":"Che","year":"2005","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.puhe.2011.01.016_bib62","first-page":"377","article-title":"Detection of HPV in genital condylomata: correlation between viral load and clinical outcome","volume":"20","author":"De Marco","year":"2001","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.puhe.2011.01.016_bib63","series-title":"United Kingdom national guideline for the management of anogenital warts","article-title":"British Association for Sexual Health and HIV (BASHH)","author":"Clinical Effectiveness Group","year":"2007"},{"key":"10.1016\/j.puhe.2011.01.016_bib64","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/sti.76.3.162","article-title":"European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts","volume":"76","author":"von Krogh","year":"2000","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.puhe.2011.01.016_bib65","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1258\/095646203321264827","article-title":"The cost-effectiveness of patient-applied treatments for anogenital warts","volume":"14","author":"Williams","year":"2003","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.puhe.2011.01.016_bib66","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines","volume":"55","author":"Workowski","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.puhe.2011.01.016_bib67","first-page":"337","article-title":"Direct medical costs for surgical and medical treatment of condylomata acuminata","volume":"137","author":"Alam","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.puhe.2011.01.016_bib68","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archderm.134.1.25","article-title":"Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human papillomavirus","volume":"134","author":"Edwards","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.puhe.2011.01.016_bib69","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/00128071-200506060-00004","article-title":"Human papillomavirus: burden of illness and treatment cost considerations","volume":"6","author":"Fox","year":"2005","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.puhe.2011.01.016_bib70","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/GRF.0b013e31818092a3","article-title":"New approaches to external genital warts and vulvar intraepithelial neoplasia","volume":"51","author":"Kennedy","year":"2008","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.puhe.2011.01.016_bib71","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/sti.79.4.270","article-title":"Randomised controlled trial and economic evaluation of podophyllotoxin solution, podophyllotoxin cream, and podophyllin in the treatment of genital warts","volume":"79","author":"Lacey","year":"2003","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.puhe.2011.01.016_bib72","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/S0149-2918(00)87244-6","article-title":"Modeling the impact of treatment options in genital warts: patient-applied versus physician-administered therapies","volume":"21","author":"Langley","year":"1999","journal-title":"Clin Ther"},{"key":"10.1016\/j.puhe.2011.01.016_bib73","first-page":"69","article-title":"The cost effectiveness of patient-applied versus provider-administered intervention strategies for the treatment of external genital warts","volume":"5","author":"Langley","year":"1999","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.puhe.2011.01.016_bib74","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/LGT.0b013e31815dd4b4","article-title":"Modern management of external genital warts","volume":"12","author":"Mayeaux","year":"2008","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.puhe.2011.01.016_bib75","series-title":"Gardasil: full prescribing information","author":"Merck & Co., Inc.","year":"2009"},{"key":"10.1016\/j.puhe.2011.01.016_bib76","unstructured":"Donovan B, Franklin N, Guy R, et\u00a0al. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis; in press."},{"key":"10.1016\/j.puhe.2011.01.016_bib77","series-title":"Price indices (MEI)","year":"2009"},{"key":"10.1016\/j.puhe.2011.01.016_bib78","unstructured":"OANDA Currency Converter. Historical exchange rates; 2009. Available from: http:\/\/www.oanda.com\/currency\/historical-rates [last accessed 16.11.2010]."},{"key":"10.1016\/j.puhe.2011.01.016_bib79","series-title":"All new STI episodes seen at GUM clinics in the UK. Number of new STI episodes seen at genitourinary medicine clinics by sex, 1999\u20132008","author":"UK Collaborative Group for HIV and STI Surveillance","year":"2009"},{"key":"10.1016\/j.puhe.2011.01.016_bib80","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1258\/095646206780070992","article-title":"Surveillance of sexually transmitted diseases in general practice: a description of trends in the Royal College of General Practitioners Weekly Returns Service between 1994 and 2001","volume":"17","author":"Simms","year":"2006","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.puhe.2011.01.016_bib81","series-title":"Table 42: selected STDs and complications \u2014 initial visits to physicians\u2019 offices, national disease and therapeutic index: United States, 1966\u20132007","article-title":"Sexually transmitted disease surveillance","author":"Centers for Disease Control and Prevention","year":"2007"},{"key":"10.1016\/j.puhe.2011.01.016_bib82","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/00007435-200111000-00006","article-title":"Condylomata acuminata (genital warts): patient demographics and treating physicians","volume":"28","author":"Fleischer","year":"2001","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.puhe.2011.01.016_bib83","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1185\/030079906X99972","article-title":"Costs of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UK","volume":"22","author":"Brown","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.puhe.2011.01.016_bib84","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1547-5069.1997.tb01136.x","article-title":"Advice from affected persons about living with human papillomavirus infection","volume":"29","author":"Taylor","year":"1997","journal-title":"Image J Nurs Sch"},{"key":"10.1016\/j.puhe.2011.01.016_bib85","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1258\/0956462981921143","article-title":"An international survey of patients with genital warts: perceptions regarding treatment and impact on lifestyle","volume":"9","author":"Maw","year":"1998","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.puhe.2011.01.016_bib86","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2340\/0001555572185186","article-title":"Follow-up of men with genital papilloma virus infection. Psychosexual aspects","volume":"72","author":"Voog","year":"1992","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.puhe.2011.01.016_bib87","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1258\/0956462011923877","article-title":"A prospective study of the psychological impact on patients of first diagnosis of human papillomavirus","volume":"12","author":"Conaglen","year":"2001","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.puhe.2011.01.016_bib88","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1258\/095646205774357334","article-title":"The role of illness perceptions: psychological distress and treatment-seeking delay in patients with genital warts","volume":"16","author":"Ireland","year":"2005","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.puhe.2011.01.016_bib89","unstructured":"Myers ER, Green S, Lipkus I. Patient preferences for health states related to HPV infection: visual analogue scales versus time trade-off elicitation. Proceedings of the 21st International papillomavirus conference, 390, Mexico City, Mexico; 2004."},{"key":"10.1016\/j.puhe.2011.01.016_bib90","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1477-7525-3-24","article-title":"Combination of qualitative and quantitative methods for developing a new health related quality of life measure for patients with anogenital warts","volume":"3","author":"Badia","year":"2005","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.puhe.2011.01.016_bib91","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1016\/j.vaccine.2007.04.086","article-title":"The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada","volume":"25","author":"Brisson","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.puhe.2011.01.016_bib92","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1471-0528.2008.01743.x","article-title":"The epidemiological and economic impact of a quadrivalent human papillomavirus vaccine (6\/11\/16\/18) in the UK","volume":"115","author":"Dasbach","year":"2008","journal-title":"BJOG"},{"key":"10.1016\/j.puhe.2011.01.016_bib93","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3201\/eid1301.060438","article-title":"Model for assessing human papillomavirus vaccination strategies","volume":"13","author":"Elbasha","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.puhe.2011.01.016_bib94","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1478-7547-6-4","article-title":"Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: a cost-effectiveness analysis","volume":"6","author":"Kulasingam","year":"2008","journal-title":"Cost Eff Resour Alloc"},{"key":"10.1016\/j.puhe.2011.01.016_bib95","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1185\/030079908X297826","article-title":"Cost-effectiveness analysis of adding a quadrivalent HPV vaccine to the cervical cancer screening programme in Switzerland","volume":"24","author":"Szucs","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.puhe.2011.01.016_bib96","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/sti.2007.029512","article-title":"Estimation of the impact of genital warts on health-related quality of life","volume":"84","author":"Woodhall","year":"2008","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.puhe.2011.01.016_bib97","first-page":"257","article-title":"Validation and clinical use of the CECA, a disease-specific quality of life questionnaire for patients with anogenital condylomata acuminata","volume":"88","author":"Vilata","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.puhe.2011.01.016_bib98","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1258\/0956462041558168","article-title":"The costs of treating external genital warts in England and Wales: a treatment pattern analysis","volume":"15","author":"Langley","year":"2004","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.puhe.2011.01.016_bib99","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2165\/00019053-200523110-00004","article-title":"Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature","volume":"23","author":"Insinga","year":"2005","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.puhe.2011.01.016_bib100","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1363\/3601104","article-title":"The estimated direct medical cost of sexually transmitted diseases among American youth, 2000","volume":"36","author":"Chesson","year":"2004","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.puhe.2011.01.016_bib101","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/sti.2009.040188","article-title":"Genital warts incidence and healthcare resource utilisation in Australia","volume":"86","author":"Pirotta","year":"2010","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.puhe.2011.01.016_bib102","article-title":"Trends in genital warts and genital herpes diagnoses in the United Kingdom","volume":"vol. 1","author":"The UK Collaborative Group for HIV and STI Surveillance","year":"2007"},{"key":"10.1016\/j.puhe.2011.01.016_bib103","first-page":"S462","article-title":"Human papillomavirus and cervical cancer: burden of illness and basis for prevention","volume":"12","author":"Trottier","year":"2006","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.puhe.2011.01.016_bib104","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0889-8545(21)00062-0","article-title":"Genital human papillomavirus infection. A growing concern","volume":"14","author":"Becker","year":"1987","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.puhe.2011.01.016_bib105","first-page":"365","article-title":"Epidemiology of genital warts in England and Wales: 1971 to 1994","volume":"73","author":"Simms","year":"1997","journal-title":"Genitourin Med"},{"key":"10.1016\/j.puhe.2011.01.016_bib106","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/sti.2004.009415","article-title":"Recent trends in the epidemiology of sexually transmitted infections in the European Union","volume":"80","author":"Fenton","year":"2004","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.puhe.2011.01.016_bib107","series-title":"Continued increase in sexually transmitted infections: an analysis of data from UK genitourinary medicine clinics up to 2007","author":"UK Collaborative Group for HIV and STI Surveillance","year":"2008"},{"key":"10.1016\/j.puhe.2011.01.016_bib108","series-title":"Selected STI diagnoses made at GUM clinics in the UK: 1999\u20132008","author":"UK Collaborative Group for HIV and STI Surveillance","year":"2009"},{"key":"10.1016\/j.puhe.2011.01.016_bib109","series-title":"Sexually transmitted disease surveillance","author":"Centers for Disease Control and Prevention","year":"2007"},{"key":"10.1016\/j.puhe.2011.01.016_bib110","doi-asserted-by":"crossref","first-page":"174","DOI":"10.12968\/bjon.1996.5.3.174","article-title":"Genital warts: a study of patient anxiety and information needs","volume":"5","author":"Chandler","year":"1996","journal-title":"Br J Nurs"},{"key":"10.1016\/j.puhe.2011.01.016_bib111","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/01674829309084437","article-title":"Psychological aspects of genital human papillomavirus infection: a preliminary report","volume":"14","author":"Filiberti","year":"1993","journal-title":"J Psychosom Obstet Gynaecol"}],"container-title":["Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033350611000369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033350611000369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T00:18:44Z","timestamp":1712621924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033350611000369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":111,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0033350611000369"],"URL":"https:\/\/doi.org\/10.1016\/j.puhe.2011.01.016","relation":{},"ISSN":["0033-3506"],"issn-type":[{"value":"0033-3506","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}